Seeking Alpha

Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Reveos is positioned to help U.S. blood centers supplement the platelet supply, reduce labor and costs, and improve overall operational efficiency LAKEWOOD, Colo., Aug. 1, 2023 /PRNewswire/ -- Terumo ...
Morningstar

The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies

LAKEWOOD, Colo., Oct. 22, 2025 /PRNewswire/ -- To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center to ...
The Victoria Advocate

Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use

Automated processing of whole blood on the Reveos system, the only device of its kind globally, will enhance the blood and platelet supply for patients in the U.S. Platelets are used to treat patients ...
MarketWatch

The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies

The MarketWatch News Department was not involved in the creation of this content. -- Second U.S. site to deploy the Reveos(TM) system, boosting platelet supply and reducing waste LAKEWOOD, Colo., Oct.